- Home
- TLX vs OPCH Comparison
TLX vs OPCH Comparison
Compare TLX & OPCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLX
- OPCH
- Stock Information
- Founded
- TLX 2015
- OPCH N/A
- Country
- TLX Australia
- OPCH United States
- Employees
- TLX N/A
- OPCH N/A
- Industry
- TLX Biotechnology: Pharmaceutical Preparations
- OPCH Medical/Nursing Services
- Sector
- TLX Health Care
- OPCH Health Care
- Exchange
- TLX Nasdaq
- OPCH Nasdaq
- Market Cap
- TLX 4.0B
- OPCH 4.6B
- IPO Year
- TLX N/A
- OPCH N/A
- Fundamental
- Price
- TLX $9.51
- OPCH $28.68
- Analyst Decision
- TLX Strong Buy
- OPCH Strong Buy
- Analyst Count
- TLX 3
- OPCH 7
- Target Price
- TLX $22.33
- OPCH $36.14
- AVG Volume (30 Days)
- TLX 217.0K
- OPCH 1.8M
- Earning Date
- TLX 01-01-0001
- OPCH 10-29-2025
- Dividend Yield
- TLX N/A
- OPCH N/A
- EPS Growth
- TLX N/A
- OPCH 5.29
- EPS
- TLX 0.04
- OPCH 1.26
- Revenue
- TLX $664,225,558.00
- OPCH $5,374,021,000.00
- Revenue This Year
- TLX N/A
- OPCH $14.82
- Revenue Next Year
- TLX N/A
- OPCH $8.49
- P/E Ratio
- TLX $298.01
- OPCH $22.72
- Revenue Growth
- TLX 55.35
- OPCH 17.07
- 52 Week Low
- TLX $9.48
- OPCH $21.39
- 52 Week High
- TLX $30.36
- OPCH $35.53
- Technical
- Relative Strength Index (RSI)
- TLX 31.15
- OPCH 49.46
- Support Level
- TLX $12.12
- OPCH $27.83
- Resistance Level
- TLX $12.58
- OPCH $29.33
- Average True Range (ATR)
- TLX 0.45
- OPCH 0.77
- MACD
- TLX 0.01
- OPCH 0.16
- Stochastic Oscillator
- TLX 0.98
- OPCH 77.89
About TLX Telix Pharmaceuticals Limited American Depositary Shares
Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.
About OPCH Option Care Health Inc.
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders among others.